Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). (Q39767081)

14 September 2017

title

Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). (English)

1 reference

14 September 2017

1 reference

Sylvie Kossodo

1

1 reference

14 September 2017

Maureen Pickarski

2

1 reference

14 September 2017

Shu-An Lin

3

1 reference

14 September 2017

Alexa Gleason

4

1 reference

14 September 2017

Renee Gaspar

5

1 reference

14 September 2017

Chiara Buono

6

1 reference

14 September 2017

Guojie Ho

7

1 reference

14 September 2017

Agnieszka Blusztajn

8

1 reference

14 September 2017

Garry Cuneo

9

1 reference

14 September 2017

Jun Zhang

10

1 reference

14 September 2017

Jayme Jensen

11

1 reference

14 September 2017

Richard Hargreaves

12

1 reference

14 September 2017

Paul Coleman

13

1 reference

14 September 2017

George Hartman

14

1 reference

14 September 2017

Milind Rajopadhye

15

1 reference

14 September 2017

Le Thi Duong

16

1 reference

14 September 2017

Cyrille Sur

17

1 reference

14 September 2017

Wael Yared

18

1 reference

14 September 2017

Jeffrey Peterson

19

1 reference

14 September 2017

Bohumil Bednar

20

1 reference

14 September 2017

publication date

4 December 2009

1 reference

Molecular Imaging and Biology

14 September 2017

published in

1 reference

14 September 2017

volume

12

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

488-499

1 reference

Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.

14 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-009-0279-Z

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

12 December 2020

Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

1 reference

12 December 2020

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

1 reference

12 December 2020

Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe

1 reference

12 December 2020

Role of integrins in cell invasion and migration

1 reference

12 December 2020

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis

1 reference

12 December 2020

Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor

1 reference

12 December 2020

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

1 reference

12 December 2020

A submillimeter resolution fluorescence molecular imaging system for small animal imaging

1 reference

12 December 2020

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

12 December 2020

The Promise of Integrins as Effective Targets for Anticancer Agents

1 reference

12 December 2020

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

1 reference

12 December 2020

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies

1 reference

12 December 2020

Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers

1 reference

12 December 2020

Looking and listening to light: the evolution of whole-body photonic imaging

1 reference

12 December 2020

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

1 reference

12 December 2020

The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities

1 reference

12 December 2020

Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)

1 reference

12 December 2020

Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts

1 reference

12 December 2020

Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature

1 reference

12 December 2020

Platelet and osteoclast β 3 integrins are critical for bone metastasis

1 reference

12 December 2020

Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling

1 reference

12 December 2020

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

1 reference

12 December 2020

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model

1 reference

12 December 2020

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

1 reference

12 December 2020

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders

1 reference

12 December 2020

Integrin ligands at a glance

1 reference

12 December 2020

Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors

1 reference

12 December 2020

Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens

1 reference

12 December 2020

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

1 reference

12 December 2020

Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival

1 reference

12 December 2020

Near-infrared optical imaging of ovarian cancer xenografts with novel alpha 3-integrin binding peptide "OA02".

1 reference

12 December 2020

Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression

1 reference

12 December 2020

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

1 reference

12 December 2020

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

1 reference

12 December 2020

Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo

1 reference

12 December 2020

Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartic acid ligands in binding to glycoprotein IIb/IIIa on platelets

1 reference

12 December 2020

The role of alpha(v)beta(3) in prostate cancer progression

1 reference

12 December 2020

Tomographic fluorescence imaging of tumor vascular volume in mice

1 reference

12 December 2020

Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis

1 reference

12 December 2020

Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin

1 reference

12 December 2020

Angiogenesis in cancer and other diseases

1 reference

12 December 2020

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer

1 reference

12 December 2020

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

12 December 2020

Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin

1 reference

12 December 2020

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts

1 reference

12 December 2020

Tomographic fluorescence mapping of tumor targets

1 reference

12 December 2020

Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives

1 reference

12 December 2020

The alphavbeta3 integrin regulates alpha5beta1-mediated cell migration toward fibronectin

1 reference

12 December 2020

The biology of integrins

1 reference

12 December 2020

Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice

1 reference

12 December 2020

Multivalent effects of RGD peptides obtained by nanoparticle display

1 reference

12 December 2020

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.

1 reference

12 December 2020

In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.

1 reference

12 December 2020

RGD and other recognition sequences for integrins

1 reference

12 December 2020

10.1007/S11307-009-0279-Z

Identifiers

DOI

1 reference

14 September 2017

1 reference